You are here

Analysis

Vaccines are finally available in many African countries, but some people there, as well as in South Asia, are wary of taking them.

JOHANNESBURG — The detection of the Omicron variant in Africa signals the next stage of the battle against Covid-19: getting many more people inoculated in poorer nations where vaccines have been scarcest in order to deter new mutations from developing.

But while world leaders sometimes talk about this as if it were largely a matter of delivering doses overseas, the experience of South Africa, at least, hints at a far more complex set of challenges.

Like many poor countries, South Africa was made to wait months for vaccines as wealthier countries monopolized them. Many countries still do not have anywhere near enough doses to inoculate their populations.

Problem, Solution, SitRep, or ?: 

SARS-CoV-2 antibody levels predict COVID vaccine efficacy, study finds

 

SARS-CoV-2 antibody concentrations predict COVID-19 vaccine effectiveness, with higher levels correlating with greater protection, according to an ongoing US phase 3 clinical trial yesterday in Science.

A team led by researchers from Fred Hutchinson Cancer Research Center in Seattle evaluated 30,420 adult recipients of the Moderna mRNA COVID-19 vaccine at 99 centers for neutralizing and binding antibodies as correlates of risk for, and protection against, infection.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Analysis
howdy folks
Page loaded in 0.695 seconds.